BioSpace News Archive

Premier Health Group is pleased to announce that as a part of its expansion plans, Premier Health will enter the Cannabis clinic space by a series of acquisitions, partnerships and/or launching a new Canada-based chain in the first half of 2019.

Mr. Cumbo, biotech industry veteran, brings commercial expertise and strategic leadership in industry-leading commercial product launches

Will 2020 be the year for Alzheimer’s disease? Yes, says Hevilo Life Sciences, which is on track to meet this goal with the announcement of early access to NE-ALZ-138 – a targeted polytherapeutic solution which to date has proven effective in reducing the risk of developing Alzheimer’s disease, and managing, delaying progression and reversing the impacts of the disease.

Many asthma patients are prescribed oral corticosteroids (OCS) to treat moderate-to-severe flares and decrease the risk of emergency department (ED) visits or hospitalizations, but with chronic use comes the potential for serious health risks.

-- In its continuing commitment to expand work-based learning and externship opportunities for students, CVS Health has announced a new collaboration with Philadelphia Job Corps, Philadelphia Works and Philadelphia Youth Network

Maxim Healthcare Services Chief Medical Officer John Langley, M.D., has been elected to chair the American Academy of Pediatrics’ (AAP) Section on Home Care (SOHC).

Bausch + Lomb, a leading global eye health company and a wholly owned subsidiary of Bausch Health Companies Inc. (NYSE:/TSX:BHC), today announced on America Recycles Day that its exclusive ONE by ONE Recycling Program has recycled a combined total of more than five million units of used contact lenses, blister packs and top foils since the program’s inception in November 2016.

The Urology Care Foundation, the world’s leading nonprofit urological health foundation and the official foundation of the American Urological Association (AUA), is pleased to announce the selection of Joel Berends as the inaugural recipient of its new Physician Scientist Residency Training Award.

Novus Therapeutics, Inc. (NASDAQ: NVUS), a specialty pharmaceutical company focused on developing products for patients with disorders of the ear, nose, and throat (ENT), today announced that management will participate in the 30th Annual Piper Jaffray Health Care Conference to be held November 27-29, 2018 at the Lotte New York Palace

ReWalk Robotics, Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) applauds United Spinal Association’s recommendation, dated November 9, 2018, that health insurance providers consider the use of powered exoskeleton devices as medically necessary for eligible individuals with spinal cord injuries